Research programme: osteoporosis therapy - Biocon
Alternative Names: NPH-002/004; NPT-002; Oral peptide - parathyroid hormone; Oral peptide - PTHLatest Information Update: 10 Apr 2007
At a glance
- Originator Biocon
- Class Peptide hormones
- Mechanism of Action Parathyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 11 May 2004 NPH 002/004 is available for licensing (http://www.nobexcorp.com)
- 11 May 2004 Preclinical trials in Osteoporosis in USA (unspecified route)